First Manhattan CO Meridian Bioscience Inc Transaction History

First Manhattan CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$7.84 - $23.29 $21,168 - $62,883	-2,700 Reduced 51.31%	2,562 $59,000
Q1 2019 Apr 12, 2019	SELL	$15.51 - $17.61 $27,918 - $31,698	-1,800 Reduced 25.49%	5,262 $92,000
Q2 2018 Aug 01, 2018	SELL	$13.8 - $16.8 $6,900 - $8,400	-500 Reduced 6.61%	7,062 $112,000
Q1 2018 Apr 20, 2018	BUY	$13.8 - $16.2 $7,755 - $9,104	562 Added 8.03%	7,562 $107,000
Q3 2017 Oct 25, 2017	BUY	$13.45 - $14.35 $94,150 - $100,450	7,000	7,000 $100,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.